AIM IMMUNOTECH INC. Deferred Tax Assets, Tax Credit Carryforwards, Foreign
AIM IMMUNOTECH INC. (AIM) had Deferred Tax Assets, Tax Credit Carryforwards, Foreign of $37.90 million as of 2020-12-31, per its 10-Q filed 2021-11-15.
Discontinued › Notes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsForeign · last filed 2021-11-15
- 2020-12-31: Deferred Tax Assets, Tax Credit Carryforwards, Foreign $37.90M.
| Period end | Deferred Tax Assets, Tax Credit Carryforwards, Foreign |
|---|---|
| 2020-12-31 | $37.90M 10-Q · filed 2021-11-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Silexion Therapeutics Corp (SLXN) | $0.001B |